Crosstalk of Notch with p53 and p63 in cancer growth control

Understanding the complexity of cancer depends on an elucidation of the underlying regulatory networks, at the cellular and intercellular levels and in their temporal dimension. This Opinion article focuses on the multilevel crosstalk between the Notch pathway and the p53 and p63 pathways. These two coordinated signalling modules are at the interface of external damaging signals and control of stem cell potential and differentiation. Positive or negative reciprocal regulation of the two pathways can vary with cell type and cancer stage. Therefore, selective or combined targeting of the two pathways could improve the efficacy and reduce the toxicity of cancer therapies.

[1]  T. Jacks,et al.  A subset of p53-deficient embryos exhibit exencephaly , 1995, Nature Genetics.

[2]  Scott Barolo,et al.  Three habits of highly effective signaling pathways: principles of transcriptional control by developmental cell signaling. , 2002, Genes & development.

[3]  M. Lacouture.  Mechanisms of cutaneous toxicities to EGFR inhibitors , 2006, Nature Reviews Cancer.

[4]  B. Osborne,et al.  p53 regulates thymic Notch1 activation , 2004, European journal of immunology.

[5]  Vikram Devgan,et al.  p 21 WAF 1 / Cip 1 is a negative transcriptional regulator of Wnt 4 expression downstream of Notch 1 activation , 2005 .

[6]  G. Dotto,et al.  Notch tumor suppressor function , 2008, Oncogene.

[7]  D. Sgroi,et al.  Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation. , 2002, Genes & development.

[8]  T. Hubbard,et al.  Large-Scale Mutagenesis in p19ARF- and p53-Deficient Mice Identifies Cancer Genes and Their Collaborative Networks , 2008, Cell.

[9]  A. Ferrando,et al.  The role of the PTEN/AKT Pathway in NOTCH1-induced leukemia , 2008, Cell cycle.

[10]  J. Caldwell,et al.  Identification of p53 regulators by genome-wide functional analysis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[11]  A. Yoo,et al.  LIN-12/Notch Activation Leads to MicroRNA-Mediated Down-Regulation of Vav in C. elegans , 2005, Science.

[12]  Julian Lewis,et al.  The vertebrate segmentation clock. , 2004, Current opinion in genetics & development.

[13]  Raphael Kopan,et al.  The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism , 2009, Cell.

[14]  A. Yang,et al.  p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. , 1998, Molecular cell.

[15]  Galit Lahav,et al.  Oscillations by the p53-Mdm2 feedback loop. , 2008, Advances in experimental medicine and biology.

[16]  S. Bray.  Notch signalling: a simple pathway becomes complex , 2006, Nature Reviews Molecular Cell Biology.

[17]  D. Ward,et al.  Human ligands of the Notch receptor. , 1999, The American journal of pathology.

[18]  英樹 仁井見.  Notch signaling is necessary for epithelial growth arrest by TGF-β , 2007 .

[19]  Y. Nakanishi,et al.  Benzo[a]pyrene Activates the Human p53 Gene through Induction of Nuclear Factor κB Activity* , 1999, The Journal of Biological Chemistry.

[20]  D. J. Jerry,et al.  Regulation of cancer stem cells by p53 , 2008, Breast Cancer Research.

[21]  J-Z Qin,et al.  Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through NF-κB and PPARγ , 2002, Cell Death and Differentiation.

[22]  G. Dotto,et al.  A dynamic model of keratinocyte stem cell renewal and differentiation: role of the p21WAF1/Cip1 and Notch1 signaling pathways. , 2004, The journal of investigative dermatology. Symposium proceedings.

[23]  J. G. Patton,et al.  MiRNA expression analysis during normal zebrafish development and following inhibition of the Hedgehog and Notch signaling pathways , 2007, Developmental dynamics : an official publication of the American Association of Anatomists.

[24]  Hae-Ock Lee,et al.  Regulation of ΔNp63α by tumor necrosis factor‐α in epithelial homeostasis , 2007, The FEBS journal.

[25]  M. Kaufman,et al.  High-frequency developmental abnormalities in p53-deficient mice , 1995, Current Biology.

[26]  K. Jones,et al.  Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex. , 2002, Genes & development.

[27]  Rhett A. Kovall,et al.  Crystal Structure of the CSL-Notch-Mastermind Ternary Complex Bound to DNA , 2006, Cell.

[28]  Sathish Kumar Mungamuri,et al.  Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53. , 2006, Cancer research.

[29]  J. Stelling,et al.  Robustness of Cellular Functions , 2004, Cell.

[30]  A. Mills,et al.  p63 regulates multiple signalling pathways required for ectodermal organogenesis and differentiation , 2006, Development.

[31]  N. Perkins,et al.  Transcriptional Cross Talk between NF-κB and p53 , 1999, Molecular and Cellular Biology.

[32]  T. Maniatis,et al.  Virus induction of human IFNβ gene expression requires the assembly of an enhanceosome , 1995, Cell.

[33]  L. Ellisen,et al.  p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. , 2006, Cancer cell.

[34]  G. Dotto,et al.  The FoxO3a gene is a key negative target of canonical Notch signalling in the keratinocyte UVB response , 2008, The EMBO journal.

[35]  Jun Yao,et al.  Growth suppression induced by Notch1 activation involves Wnt—β‐catenin down‐regulation in human tongue carcinoma cells , 2006, Biology of the cell.

[36]  R. Soldi,et al.  Notch Activation Suppresses Fibroblast Growth Factor-dependent Cellular Transformation* , 2003, The Journal of Biological Chemistry.

[37]  T. Golde,et al.  ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a γ-secretase inhibitor , 2008, Oncogene.

[38]  Freddy Radtke,et al.  Multiple roles of Notch signaling in the regulation of epidermal development. , 2008, Developmental cell.

[39]  David P Lane,et al.  p53 isoforms can regulate p53 transcriptional activity. , 2005, Genes & development.

[40]  Eduardo Sontag,et al.  Transcriptional control of human p53-regulated genes , 2008, Nature Reviews Molecular Cell Biology.

[41]  J. Zavadil,et al.  Integration of TGF‐β/Smad and Jagged1/Notch signalling in epithelial‐to‐mesenchymal transition , 2004 .

[42]  Galit Lahav,et al.  The Strength of Indecisiveness: Oscillatory Behavior for Better Cell Fate Determination , 2004, Science's STKE.

[43]  A. Contente,et al.  A mediates negative regulation of transcription by p 53 , 2003 .

[44]  B. tenOever,et al.  Overlapping and distinct mechanisms regulating IRF-3 and IRF-7 function. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[45]  F. Alimirah,et al.  Restoration of p53 expression in human cancer cell lines upregulates the expression of Notch1: implications for cancer cell fate determination after genotoxic stress. , 2007, Neoplasia.

[46]  J. Aster,et al.  The multifaceted role of Notch in cancer. , 2007, Current opinion in genetics & development.

[47]  Daniel Medina,et al.  Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. , 2008, Cancer research.

[48]  N. Dean,et al.  Defining the transcriptome of accelerated and replicatively senescent keratinocytes reveals links to differentiation, interferon signaling, and Notch related pathways , 2006, Journal of cellular biochemistry.

[49]  R. Bernards,et al.  The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene , 2005, Nature Cell Biology.

[50]  J. Pietenpol,et al.  p63: Molecular complexity in development and cancer. , 2004, Carcinogenesis.

[51]  A. Capobianco,et al.  Induction of Cyclin D1 Transcription and CDK2 Activity by Notchic: Implication for Cell Cycle Disruption in Transformation by Notchic , 2001, Molecular and Cellular Biology.

[52]  T. Golde,et al.  Off the beaten pathway: the complex cross talk between Notch and NF-κB , 2008, Laboratory Investigation.

[53]  G. Dotto,et al.  Notch signaling in the integrated control of keratinocyte growth/differentiation and tumor suppression. , 2004, Seminars in cancer biology.

[54]  Ryan T. Phan,et al.  The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells , 2004, Nature.

[55]  T. Kadesch,et al.  Consequences of Notch-mediated induction of Jagged1. , 2004, Experimental cell research.

[56]  W. Pear,et al.  Impaired notch signaling promotes de novo squamous cell carcinoma formation. , 2006, Cancer research.

[57]  S. Lovestone,et al.  TAp73 isoforms antagonize Notch signalling in SH‐SY5Y neuroblastomas and in primary neurones , 2006, Journal of neurochemistry.

[58]  Larry Kedes,et al.  HES and HERP families: Multiple effectors of the notch signaling pathway , 2003, Journal of cellular physiology.

[59]  John M Sedivy,et al.  Stress response gene ATF3 is a target of c‐myc in serum‐induced cell proliferation , 2005, The EMBO journal.

[60]  S. Artavanis-Tsakonas,et al.  Crossing paths with Notch in the hyper-network. , 2007, Current opinion in cell biology.

[61]  R. Honda,et al.  Mammalian Numb is a target protein of Mdm2, ubiquitin ligase. , 2003, Biochemical and biophysical research communications.

[62]  K. Suszták,et al.  The Notch pathway in podocytes plays a role in the development of glomerular disease , 2008, Nature Medicine.

[63]  S. Nomoto,et al.  ΔNp63α and TAp63α regulate transcription of genes with distinct biological functions in cancer and development , 2003 .

[64]  Xuetao Cao,et al.  Notch 1 Signaling Inhibits Growth of Human Hepatocellular Carcinoma through Induction of Cell Cycle Arrest and Apoptosis , 2003 .

[65]  H. Okano,et al.  rugose (rg), a Drosophila A kinase anchor protein, is required for retinal pattern formation and interacts genetically with multiple signaling pathways. , 2002, Genetics.

[66]  A. Capobianco,et al.  It's T-ALL about Notch , 2008, Oncogene.

[67]  L. Wu,et al.  Mastermind-like transcriptional co-activators: emerging roles in regulating cross talk among multiple signaling pathways , 2008, Oncogene.

[68]  F. Oswald,et al.  p300 Acts as a Transcriptional Coactivator for Mammalian Notch-1 , 2001, Molecular and Cellular Biology.

[69]  G. Mukherjee,et al.  The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions. , 1997, The Journal of general virology.

[70]  T. Schroeder,et al.  Notch1 activation reduces proliferation in the multipotent hematopoietic progenitor cell line FDCP-mix through a p53-dependent pathway but Notch1 effects on myeloid and erythroid differentiation are independent of p53 , 2008, Cell Death and Differentiation.

[71]  Elaine Fuchs,et al.  A skin microRNA promotes differentiation by repressing ‘stemness’ , 2008, Nature.

[72]  S. Piccolo.  p53 Regulation Orchestrates the TGF-β Response , 2008, Cell.

[73]  P. Kincade,et al.  Wnt-related molecules and signaling pathway equilibrium in hematopoiesis. , 2009, Cell stem cell.

[74]  Gerald C. Chu,et al.  P53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation , 2008, Nature.

[75]  M. Goumans,et al.  Synergy and antagonism between Notch and BMP receptor signaling pathways in endothelial cells , 2004, The EMBO journal.

[76]  Govind Bhagat,et al.  Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia , 2007, Nature Medicine.

[77]  U. Alon.  Network motifs: theory and experimental approaches , 2007, Nature Reviews Genetics.

[78]  K. Somasundaram,et al.  Activated Notch1 Inhibits p53-Induced Apoptosis and Sustains Transformation by Human Papillomavirus Type 16 E6 and E7 Oncogenes through a PI3K-PKB/Akt-Dependent Pathway , 2003, Journal of Virology.

[79]  Q. Su,et al.  Notch-1 regulates transcription of the epidermal growth factor receptor through p53. , 2008, Carcinogenesis.

[80]  Hannah H. Chang,et al.  Transcriptome-wide noise controls lineage choice in mammalian progenitor cells , 2008, Nature.

[81]  T. Stiewe,et al.  The p53 family in differentiation and tumorigenesis , 2007, Nature Reviews Cancer.

[82]  Julian Lewis,et al.  From Signals to Patterns: Space, Time, and Mathematics in Developmental Biology , 2008, Science.

[83]  D. Felsher,et al.  Suppression of p53 by Notch in lymphomagenesis: implications for initiation and regression. , 2005, Cancer research.

[84]  H. zur Hausen.  Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. , 2000, Journal of the National Cancer Institute.

[85]  B. Armstrong,et al.  The epidemiology of UV induced skin cancer. , 2001, Journal of photochemistry and photobiology. B, Biology.

[86]  F. Watt,et al.  Role of the Notch ligand Delta1 in embryonic and adult mouse epidermis. , 2008, The Journal of investigative dermatology.

[87]  Hans Clevers,et al.  Notch1 functions as a tumor suppressor in mouse skin , 2003, Nature Genetics.

[88]  L. Wang,et al.  Overexpressed active Notch1 induces cell growth arrest of HeLa cervical carcinoma cells , 2006, International Journal of Gynecologic Cancer.

[89]  Yusuke Nakamura,et al.  The p53 Family Member Genes Are Involved in the Notch Signal Pathway* , 2002, The Journal of Biological Chemistry.

[90]  P. Khavari,et al.  Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB , 1998 .

[91]  I. Onoyama,et al.  Notch-dependent cell cycle arrest and apoptosis in mouse embryonic fibroblasts lacking Fbxw7 , 2008, Oncogene.

[92]  K. Politi,et al.  Notch in mammary gland development and breast cancer. , 2004, Seminars in cancer biology.

[93]  J. Aster,et al.  MAML 1 , a human homologue of Drosophila Mastermind , is a transcriptional coactivator for NOTCH receptors , 2000 .

[94]  F. Watt,et al.  Stimulation of human epidermal differentiation by Delta–Notch signalling at the boundaries of stem-cell clusters , 2000, Current Biology.

[95]  D. Israeli,et al.  Behavioral alterations associated with apoptosis and down-regulation of presenilin 1 in the brains of p53-deficient mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[96]  Mark Shackleton,et al.  Efficient tumour formation by single human melanoma cells , 2008 .

[97]  R. Klein,et al.  Notch activation induces apoptosis in neural progenitor cells through a p53-dependent pathway. , 2004, Developmental biology.

[98]  T. Park,et al.  Activated Notch1 interacts with p53 to inhibit its phosphorylation and transactivation , 2007, Cell Death and Differentiation.

[99]  F. D. de Gruijl.  Skin cancer and solar UV radiation. , 1999, European journal of cancer.

[100]  A. Yang,et al.  p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours , 2000, Nature.

[101]  Hideo Negishi,et al.  IRF-7 is the master regulator of type-I interferon-dependent immune responses , 2005, Nature.

[102]  Pier Paolo Di Fiore,et al.  NUMB controls p53 tumour suppressor activity , 2008, Nature.

[103]  J. Pagano,et al.  Structure and function of IRF-7. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[104]  D. Reisman,et al.  RBP‐Jκ binds to and represses transcription of the p53 tumor suppressor gene , 2009, Cell biology international.

[105]  D. Roop,et al.  The role of p63 in development and differentiation of the epidermis. , 2004, Journal of dermatological science.

[106]  H. Vogel,et al.  p63 is a p53 homologue required for limb and epidermal morphogenesis , 1999, Nature.

[107]  Goberdhan P Dimri,et al.  The Notch Regulator MAML1 Interacts with p53 and Functions as a Coactivator* , 2007, Journal of Biological Chemistry.

[108]  Nicolò Riggi,et al.  The Biology of Ewing sarcoma. , 2007, Cancer letters.

[109]  J. Kimble,et al.  Mastermind is a putative activator for Notch , 2000, Current Biology.

[110]  M. Pittelkow,et al.  EGF-receptor tyrosine kinase inhibition induces keratinocyte growth arrest and terminal differentiation. , 1997, The Journal of investigative dermatology.

[111]  M. Olivier,et al.  Recent advances in p53 research: an interdisciplinary perspective , 2009, Cancer Gene Therapy.

[112]  S. Deb,et al.  Wild-type human p53 activates the human epidermal growth factor receptor promoter. , 1994, Oncogene.

[113]  P. Khavari,et al.  Control of Keratinocyte Proliferation and Differentiation by p63 , 2007, Cell cycle.

[114]  Z. Saifudeen,et al.  A role for p53 in terminal epithelial cell differentiation. , 2002, The Journal of clinical investigation.

[115]  M. Varella‐Garcia,et al.  Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation , 2008, Nature.

[116]  J. Pietenpol,et al.  The ΔNp63α Phosphoprotein Binds the p21 and 14-3-3σ Promoters In Vivo and Has Transcriptional Repressor Activity That Is Reduced by Hay-Wells Syndrome-Derived Mutations , 2003, Molecular and Cellular Biology.

[117]  K. H. Kim,et al.  Acute effects of UVB radiation on the proliferation and differentiation of keratinocytes , 2002, Photodermatology, photoimmunology & photomedicine.

[118]  J. Aster,et al.  c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. , 2006, Genes & development.

[119]  W. Loging,et al.  Transcriptional regulation of the p53 tumor suppressor gene. , 1998, Seminars in cancer biology.

[120]  P. Secchiero,et al.  Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism. , 2009, Blood.

[121]  J. Thélu,et al.  Notch signalling is linked to epidermal cell differentiation level in basal cell carcinoma, psoriasis and wound healing , 2002, BMC dermatology.

[122]  A. Wallberg,et al.  A proline repeat domain in the Notch co-activator MAML1 is important for the p300-mediated acetylation of MAML1. , 2007, The Biochemical journal.

[123]  D. Israeli,et al.  Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1 and results in apoptosis and tumor suppression , 1998, Nature Medicine.

[124]  F. Watt,et al.  Sic transit gloria: farewell to the epidermal transit amplifying cell? , 2007, Cell stem cell.

[125]  Andrew P. Weng,et al.  Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia , 2004, Science.

[126]  Keishi Yamashita,et al.  Differential Recognition of Response Elements Determines Target Gene Specificity forp53 and p63 , 2005, Molecular and Cellular Biology.

[127]  D. Reisman,et al.  C/EBPβ Participates in Regulating Transcription of the p53 Gene in Response to Mitogen Stimulation* , 2007, Journal of Biological Chemistry.

[128]  S. Artavanis-Tsakonas,et al.  Alterations in Notch signaling in neoplastic lesions of the human cervix. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[129]  Christopher P. Crum,et al.  p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development , 1999, Nature.

[130]  L. Ährlund‐Richter,et al.  Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling. , 1999, Cancer research.

[131]  L. Donehower,et al.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.

[132]  Jon C. Aster,et al.  Structural Basis for Cooperativity in Recruitment of MAML Coactivators to Notch Transcription Complexes , 2006, Cell.

[133]  X. Wu,et al.  Notch1 induces cell cycle arrest and apoptosis in human cervical cancer cells: involvement of nuclear factor kappa B inhibition , 2006, International Journal of Gynecologic Cancer.

[134]  Ian A. White,et al.  CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. , 2008, The Journal of clinical investigation.

[135]  G. Wahl,et al.  Regulating the p53 pathway: in vitro hypotheses, in vivo veritas , 2006, Nature Reviews Cancer.

[136]  J. Grandis,et al.  Epidermal growth factor receptor biology in head and neck cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[137]  F. McKeon.  p63 and the epithelial stem cell: more than status quo? , 2004, Genes & development.

[138]  R. Knight,et al.  miR-203 represses ‘stemness’ by repressing ΔNp63 , 2008, Cell Death and Differentiation.

[139]  C. Leonetti,et al.  Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpoint. , 2006, Cancer cell.

[140]  Jian Wang,et al.  Cross-regulation between Notch and p63 in keratinocyte commitment to differentiation. , 2006, Genes & development.

[141]  Freddy Radtke,et al.  Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation , 2001, The EMBO journal.

[142]  Shuichi Tsutsumi,et al.  A global map of p53-binding sites in the human genome , 2007 .